2022
Childhood tuberculosis and factors associated with mortality and loss to follow-up at a major paediatric treatment centre in Southern Ghana.
The Pan African medical journal
PubMed • Publisher's siteUpdate your location to show providers, locations, and services closest to you.
Infectious Disease Specialist
Dr. Kwara’s research is focused on clinical pharmacology of antiretroviral and antituberculosis therapy in persons living with human immunodeficiency virus (HIV) with tuberculosis (TB) or hepatitis B virus (HBV) coinfection. He is the PI of NIH that seeks to investigate the pharmacokinetics, drug-drug interactions and pharmacogenetic determinants of HIV, HBV and TB treatment outcomes. His work with collaborators in the US and Ghana seeks to unravel the molecular basis for the inter-individual variability in TB, HBV and HIV drugs pharmacokinetics, and drug-drug interactions in individuals with HIV and TB coinfection. Dr. Kwara collaborates with colleagues at the Center for Pharmacogenenomics in the Department of Pharmacotherapy and Translation Research at UF College of Pharmacy. Beyond the field of HIV therapeutics, our research could inform how pharmacogenomics and/or applied pharmacokinetics can be used to optimize the treatment outcome of common infectious diseases at the individual and population levels.
79 publications
2022
The Pan African medical journal
PubMed • Publisher's site2022
AIDS and behavior
PubMed • Publisher's site2021
Pharmacogenomics
Publisher's site2021
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
PubMed • Publisher's site2021
BMC infectious diseases
PubMed • Publisher's site